These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2450 related items for PubMed ID: 28184163

  • 1. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P, Haddadi A.
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [Abstract] [Full Text] [Related]

  • 2. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.
    Senthilkumar M, Mishra P, Jain NK.
    J Drug Target; 2008 Jun; 16(5):424-35. PubMed ID: 18569287
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug Delivery.
    Rafiei P, Haddadi A.
    Pharm Nanotechnol; 2017 Jun; 5(1):3-23. PubMed ID: 28948907
    [Abstract] [Full Text] [Related]

  • 4. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS, Mei L, Anitha P, Gan CW, Zhou W.
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM, Zhang L, Yuet KP, Liao G, Rhee JW, Langer R, Farokhzad OC.
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [Abstract] [Full Text] [Related]

  • 7. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
    Lin TsT, Gao DY, Liu YC, Sung YC, Wan D, Liu JY, Chiang T, Wang L, Chen Y.
    J Control Release; 2016 Jan 10; 221():62-70. PubMed ID: 26551344
    [Abstract] [Full Text] [Related]

  • 8. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z, Huang H, Huang L, Du L, Sun Y, Duan Y.
    Int J Mol Sci; 2017 Apr 13; 18(4):. PubMed ID: 28406431
    [Abstract] [Full Text] [Related]

  • 9. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
    Rietscher R, Schröder M, Janke J, Czaplewska J, Gottschaldt M, Scherließ R, Hanefeld A, Schubert US, Schneider M, Knolle PA, Lehr CM.
    Eur J Pharm Biopharm; 2016 May 13; 102():20-31. PubMed ID: 26940132
    [Abstract] [Full Text] [Related]

  • 10. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
    Pradhan R, Poudel BK, Ramasamy T, Choi HG, Yong CS, Kim JO.
    J Nanosci Nanotechnol; 2013 Aug 13; 13(8):5948-56. PubMed ID: 23882865
    [Abstract] [Full Text] [Related]

  • 11. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.
    Graves RA, Ledet GA, Glotser EY, Mitchner DM, Bostanian LA, Mandal TK.
    Eur J Pharm Sci; 2015 Aug 30; 76():1-9. PubMed ID: 25933716
    [Abstract] [Full Text] [Related]

  • 12. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
    Tao W, Zeng X, Liu T, Wang Z, Xiong Q, Ouyang C, Huang L, Mei L.
    Acta Biomater; 2013 Nov 30; 9(11):8910-20. PubMed ID: 23816645
    [Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N, Alam MA, Ahmad R, Naqvi AA, Ahmad FJ.
    Artif Cells Nanomed Biotechnol; 2018 Mar 30; 46(2):432-446. PubMed ID: 28503995
    [Abstract] [Full Text] [Related]

  • 14. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.
    Derakhshandeh K, Soheili M, Dadashzadeh S, Saghiri R.
    Int J Nanomedicine; 2010 Aug 09; 5():463-71. PubMed ID: 20957168
    [Abstract] [Full Text] [Related]

  • 15. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
    Rafiei P, Haddadi A.
    Mater Sci Eng C Mater Biol Appl; 2019 Nov 09; 104():109950. PubMed ID: 31499976
    [Abstract] [Full Text] [Related]

  • 16. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
    Avgoustakis K.
    Curr Drug Deliv; 2004 Oct 09; 1(4):321-33. PubMed ID: 16305394
    [Abstract] [Full Text] [Related]

  • 17. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
    Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC.
    Biomaterials; 2007 Feb 09; 28(5):869-76. PubMed ID: 17055572
    [Abstract] [Full Text] [Related]

  • 18. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP.
    Nanomedicine; 2007 Dec 09; 3(4):246-57. PubMed ID: 18068091
    [Abstract] [Full Text] [Related]

  • 19. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM, Alomrani AH, Harisa GI, Ashour AE, Kumar A, Yassin AE.
    Biomed Pharmacother; 2018 Oct 09; 106():1461-1468. PubMed ID: 30119220
    [Abstract] [Full Text] [Related]

  • 20. Robust aptamer-polydopamine-functionalized M-PLGA-TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapy.
    Xu G, Yu X, Zhang J, Sheng Y, Liu G, Tao W, Mei L.
    Int J Nanomedicine; 2016 Oct 09; 11():2953-65. PubMed ID: 27382282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 123.